| scholarly article | Q13442814 |
| P50 | author | Andrew J. Brooks | Q55155147 |
| Aaron G Smith | Q55474040 | ||
| Louise F Nikolajsen | Q57189221 | ||
| Yash Chhabra | Q58241725 | ||
| Frederic A Meunier | Q41876596 | ||
| P2093 | author name string | H Y Wong | |
| M J Waters | |||
| A Papadopulos | |||
| B B Kragelund | |||
| H Steinocher | |||
| K A Tunny | |||
| P2860 | cites work | Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans | Q24618226 |
| Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases | Q27644446 | ||
| Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis | Q50537419 | ||
| Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women. | Q51544982 | ||
| Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. | Q54532552 | ||
| Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma. | Q54567241 | ||
| Role of the growth hormone–IGF-1 axis in cancer | Q57252658 | ||
| Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array | Q74599391 | ||
| Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat | Q78086501 | ||
| Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice | Q80594368 | ||
| Stabilization of prolactin receptor in breast cancer cells | Q81461032 | ||
| Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer | Q37602926 | ||
| SOCS proteins in development and disease | Q38124037 | ||
| Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes | Q38890517 | ||
| Cigarette smoke extract-induced BEAS-2B cell apoptosis and anti-oxidative Nrf-2 up-regulation are mediated by ROS-stimulated p38 activation | Q38964879 | ||
| Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma | Q39669033 | ||
| Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor | Q40006280 | ||
| The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor | Q40133210 | ||
| Generation of mammalian cells stably expressing multiple genes at predetermined levels. | Q40880769 | ||
| Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone | Q41080169 | ||
| Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation | Q41160052 | ||
| Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies | Q41310543 | ||
| The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. | Q42123048 | ||
| Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling | Q42449457 | ||
| Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature | Q42509194 | ||
| Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. | Q42824711 | ||
| Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility | Q43121399 | ||
| Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span | Q44559269 | ||
| Increased site 1 affinity improves biopotency of porcine growth hormone. Evidence against diffusion dependent receptor dimerization | Q45009213 | ||
| Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer | Q46197377 | ||
| Lung cancer risk associated with Thr495Pro polymorphism of GHR in Chinese population | Q46734178 | ||
| Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer | Q46831080 | ||
| Activity-driven relaxation of the cortical actomyosin II network synchronizes Munc18-1-dependent neurosecretory vesicle docking | Q48222351 | ||
| Structure of the SOCS4-ElonginB/C Complex Reveals a Distinct SOCS Box Interface and the Molecular Basis for SOCS-Dependent EGFR Degradation | Q27649020 | ||
| Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega | Q27860809 | ||
| Gigantism in mice lacking suppressor of cytokine signalling-2 | Q28140549 | ||
| Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b) | Q28201918 | ||
| Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes | Q28209474 | ||
| A versatile viral system for expression and depletion of proteins in mammalian cells | Q28475909 | ||
| The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels | Q28477287 | ||
| Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor | Q28512825 | ||
| Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization | Q28575745 | ||
| Plat-E: an efficient and stable system for transient packaging of retroviruses | Q29614830 | ||
| Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender | Q30306091 | ||
| Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion | Q30449397 | ||
| Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data | Q30934284 | ||
| ELM 2016--data update and new functionality of the eukaryotic linear motif resource | Q31029065 | ||
| Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme | Q31114297 | ||
| Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women | Q33817664 | ||
| The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. | Q33855162 | ||
| SOCS: physiological suppressors of cytokine signaling | Q33980423 | ||
| RefDB: a database of uniformly referenced protein chemical shifts | Q34185511 | ||
| Inhibitors of cytokine signal transduction | Q34275568 | ||
| Regulation of cytokine signaling by SOCS family molecules | Q34279652 | ||
| Mechanism of activation of protein kinase JAK2 by the growth hormone receptor | Q34420222 | ||
| The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth | Q34502673 | ||
| Variants in the GH-IGF axis confer susceptibility to lung cancer | Q34655360 | ||
| A single arginine residue determines species specificity of the human growth hormone receptor | Q34667715 | ||
| Height, leg length, and cancer risk: a systematic review | Q34794311 | ||
| Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer | Q35034550 | ||
| Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids | Q35062969 | ||
| Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer | Q35256618 | ||
| Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. | Q35941268 | ||
| Negative regulation of growth hormone receptor signaling. | Q36203869 | ||
| Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice | Q37153965 | ||
| Regulatory mechanisms of growth hormone secretion are sexually dimorphic | Q37387125 | ||
| Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone | Q37589848 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 489-501 | |
| P577 | publication date | 2017-10-02 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation | |
| P478 | volume | 37 |
| Q91703988 | Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity |
| Q61797690 | Targeting growth hormone function: strategies and therapeutic applications |
| Q51766789 | The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects |
| Q94555032 | The effects of growth hormone on therapy resistance in cancer |
Search more.